Cargando…
Development of a patient-reported outcome questionnaire for aplastic anemia and paroxysmal nocturnal hemoglobinuria (PRO-AA/PNH)
BACKGROUND: The introduction of new therapy modalities has significantly improved the outcome of aplastic anemia (AA) and paroxysmal nocturnal hemoglobinuria (PNH) patients. However, relatively little is known about the exact disease burden of AA/PNH since standardized assessments of symptoms includ...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7495826/ https://www.ncbi.nlm.nih.gov/pubmed/32943103 http://dx.doi.org/10.1186/s13023-020-01532-3 |
_version_ | 1783582968291262464 |
---|---|
author | Weisshaar, Kimmo Ewald, Hannah Halter, Jörg Gerull, Sabine Schönfeld, Sandra Senft, Yuliya Martinez, Maria Leuppi-Taegtmeyer, Anne Khanna, Nina Maier, Birgit Risitano, Antonio Peffault de Latour, Regis Tichelli, Andre Passweg, Jakob Drexler, Beatrice |
author_facet | Weisshaar, Kimmo Ewald, Hannah Halter, Jörg Gerull, Sabine Schönfeld, Sandra Senft, Yuliya Martinez, Maria Leuppi-Taegtmeyer, Anne Khanna, Nina Maier, Birgit Risitano, Antonio Peffault de Latour, Regis Tichelli, Andre Passweg, Jakob Drexler, Beatrice |
author_sort | Weisshaar, Kimmo |
collection | PubMed |
description | BACKGROUND: The introduction of new therapy modalities has significantly improved the outcome of aplastic anemia (AA) and paroxysmal nocturnal hemoglobinuria (PNH) patients. However, relatively little is known about the exact disease burden of AA/PNH since standardized assessments of symptoms including health-related quality of life (HRQoL) are frequently missing or inadequately designed for this rare patient group. We aimed to develop AA/PNH-specific questionnaires for self-reporting of symptoms, which could be included in electronic platforms for data collection and patient care. METHODS: By scoping review, we extracted any reported symptoms in AA/PNH and their prevalence from the literature (Phase I). Consensus rounds with patients and medical experts were conducted to identify core symptoms reported in the literature and to add missing items (Phase II). Ultimately, AA/PNH-specific patient-reported outcome (PRO) questionnaires including the selected measures were designed (Phase III). RESULTS: AA symptoms from 62 and PNH symptoms from 45 observational studies were extracted from the literature. Twenty-four patients and seven medical experts identified 11 core symptoms including HRQoL issues after three consensus rounds. Significant differences in the symptom ranking of patients versus medical experts could be observed. Therefore, patient- as well as expert-centered PRO questionnaires in AA and PNH were created following the concepts of validated instruments. CONCLUSION: The development of symptom self-reporting questionnaires for AA and PNH was feasible and the disease-specific PRO questionnaires can now be validated within a web-based workflow in a subsequent feasibility study. |
format | Online Article Text |
id | pubmed-7495826 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-74958262020-09-23 Development of a patient-reported outcome questionnaire for aplastic anemia and paroxysmal nocturnal hemoglobinuria (PRO-AA/PNH) Weisshaar, Kimmo Ewald, Hannah Halter, Jörg Gerull, Sabine Schönfeld, Sandra Senft, Yuliya Martinez, Maria Leuppi-Taegtmeyer, Anne Khanna, Nina Maier, Birgit Risitano, Antonio Peffault de Latour, Regis Tichelli, Andre Passweg, Jakob Drexler, Beatrice Orphanet J Rare Dis Research BACKGROUND: The introduction of new therapy modalities has significantly improved the outcome of aplastic anemia (AA) and paroxysmal nocturnal hemoglobinuria (PNH) patients. However, relatively little is known about the exact disease burden of AA/PNH since standardized assessments of symptoms including health-related quality of life (HRQoL) are frequently missing or inadequately designed for this rare patient group. We aimed to develop AA/PNH-specific questionnaires for self-reporting of symptoms, which could be included in electronic platforms for data collection and patient care. METHODS: By scoping review, we extracted any reported symptoms in AA/PNH and their prevalence from the literature (Phase I). Consensus rounds with patients and medical experts were conducted to identify core symptoms reported in the literature and to add missing items (Phase II). Ultimately, AA/PNH-specific patient-reported outcome (PRO) questionnaires including the selected measures were designed (Phase III). RESULTS: AA symptoms from 62 and PNH symptoms from 45 observational studies were extracted from the literature. Twenty-four patients and seven medical experts identified 11 core symptoms including HRQoL issues after three consensus rounds. Significant differences in the symptom ranking of patients versus medical experts could be observed. Therefore, patient- as well as expert-centered PRO questionnaires in AA and PNH were created following the concepts of validated instruments. CONCLUSION: The development of symptom self-reporting questionnaires for AA and PNH was feasible and the disease-specific PRO questionnaires can now be validated within a web-based workflow in a subsequent feasibility study. BioMed Central 2020-09-17 /pmc/articles/PMC7495826/ /pubmed/32943103 http://dx.doi.org/10.1186/s13023-020-01532-3 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Weisshaar, Kimmo Ewald, Hannah Halter, Jörg Gerull, Sabine Schönfeld, Sandra Senft, Yuliya Martinez, Maria Leuppi-Taegtmeyer, Anne Khanna, Nina Maier, Birgit Risitano, Antonio Peffault de Latour, Regis Tichelli, Andre Passweg, Jakob Drexler, Beatrice Development of a patient-reported outcome questionnaire for aplastic anemia and paroxysmal nocturnal hemoglobinuria (PRO-AA/PNH) |
title | Development of a patient-reported outcome questionnaire for aplastic anemia and paroxysmal nocturnal hemoglobinuria (PRO-AA/PNH) |
title_full | Development of a patient-reported outcome questionnaire for aplastic anemia and paroxysmal nocturnal hemoglobinuria (PRO-AA/PNH) |
title_fullStr | Development of a patient-reported outcome questionnaire for aplastic anemia and paroxysmal nocturnal hemoglobinuria (PRO-AA/PNH) |
title_full_unstemmed | Development of a patient-reported outcome questionnaire for aplastic anemia and paroxysmal nocturnal hemoglobinuria (PRO-AA/PNH) |
title_short | Development of a patient-reported outcome questionnaire for aplastic anemia and paroxysmal nocturnal hemoglobinuria (PRO-AA/PNH) |
title_sort | development of a patient-reported outcome questionnaire for aplastic anemia and paroxysmal nocturnal hemoglobinuria (pro-aa/pnh) |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7495826/ https://www.ncbi.nlm.nih.gov/pubmed/32943103 http://dx.doi.org/10.1186/s13023-020-01532-3 |
work_keys_str_mv | AT weisshaarkimmo developmentofapatientreportedoutcomequestionnaireforaplasticanemiaandparoxysmalnocturnalhemoglobinuriaproaapnh AT ewaldhannah developmentofapatientreportedoutcomequestionnaireforaplasticanemiaandparoxysmalnocturnalhemoglobinuriaproaapnh AT halterjorg developmentofapatientreportedoutcomequestionnaireforaplasticanemiaandparoxysmalnocturnalhemoglobinuriaproaapnh AT gerullsabine developmentofapatientreportedoutcomequestionnaireforaplasticanemiaandparoxysmalnocturnalhemoglobinuriaproaapnh AT schonfeldsandra developmentofapatientreportedoutcomequestionnaireforaplasticanemiaandparoxysmalnocturnalhemoglobinuriaproaapnh AT senftyuliya developmentofapatientreportedoutcomequestionnaireforaplasticanemiaandparoxysmalnocturnalhemoglobinuriaproaapnh AT martinezmaria developmentofapatientreportedoutcomequestionnaireforaplasticanemiaandparoxysmalnocturnalhemoglobinuriaproaapnh AT leuppitaegtmeyeranne developmentofapatientreportedoutcomequestionnaireforaplasticanemiaandparoxysmalnocturnalhemoglobinuriaproaapnh AT khannanina developmentofapatientreportedoutcomequestionnaireforaplasticanemiaandparoxysmalnocturnalhemoglobinuriaproaapnh AT maierbirgit developmentofapatientreportedoutcomequestionnaireforaplasticanemiaandparoxysmalnocturnalhemoglobinuriaproaapnh AT risitanoantonio developmentofapatientreportedoutcomequestionnaireforaplasticanemiaandparoxysmalnocturnalhemoglobinuriaproaapnh AT peffaultdelatourregis developmentofapatientreportedoutcomequestionnaireforaplasticanemiaandparoxysmalnocturnalhemoglobinuriaproaapnh AT tichelliandre developmentofapatientreportedoutcomequestionnaireforaplasticanemiaandparoxysmalnocturnalhemoglobinuriaproaapnh AT passwegjakob developmentofapatientreportedoutcomequestionnaireforaplasticanemiaandparoxysmalnocturnalhemoglobinuriaproaapnh AT drexlerbeatrice developmentofapatientreportedoutcomequestionnaireforaplasticanemiaandparoxysmalnocturnalhemoglobinuriaproaapnh |